Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

18.44
-0.6800-3.56%
Volume:1.15M
Turnover:21.11M
Market Cap:3.59B
PE:-36.82
High:18.91
Open:18.91
Low:18.09
Close:19.12
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:193.53M
Volume Ratio:0.97
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.92
PE(LYR):-11.38

Loading ...

J&J Mastered Cancer Biotech Deals on the Cheap. Can it Stay on the Cutting Edge? -- Heard on the Street -- WSJ

Dow Jones
·
May 28

GENSCRIPT BIO Surges Over 5% Following Partner Legend Biotech's ASCO 2026 Research Presentations

Stock News
·
May 27

A Look At Legend Biotech (LEGN) Valuation After Its Strong Q1 2026 Revenue And Narrower Net Loss

Simply Wall St.
·
May 22

Legend Biotech to Showcase New CAR-T Data at ASCO 2026

TIPRANKS
·
May 22

Legend Biotech presents preliminary Phase 1 LB2102 data in small-cell lung cancer at ASCO 2026

Reuters
·
May 22

Legend Biotech Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
May 18

Analysts Are Bullish on Top Healthcare Stocks: Legend Biotech (LEGN), Krystal Biotech (KRYS)

TIPRANKS
·
May 18

HHLR's Q1 Portfolio: Capital Flows to Semiconductor Sector, PDD and Alibaba Remain Top Holdings

Stock News
·
May 16

These Analysts Revise Their Forecasts On Legend Biotech After Q1 Results

Benzinga Earnings
·
May 14

Legend Biotech price target lowered to $48 from $49 at Morgan Stanley

TIPRANKS
·
May 14

Legend Biotech Is Maintained at Outperform by RBC Capital

Dow Jones
·
May 13

Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says

MT Newswires Live
·
May 13

Legend Biotech price target raised to $64 from $62 at RBC Capital

TIPRANKS
·
May 13

RBC Lifts Price Target on Legend Biotech to $64 From $62, Keeps Outperform Rating

MT Newswires Live
·
May 13

Analysts Are Bullish on These Healthcare Stocks: AnaptysBio (ANAB), Legend Biotech (LEGN)

TIPRANKS
·
May 13

Barclays Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
May 13

Legend Biotech Corp : TD Cowen Raises Target Price to $29 From $21

THOMSON REUTERS
·
May 13

GENSCRIPT BIO Surges Over 5% as Associate Legend Biotech Reports Narrowed Loss and Strong CARVYKTI® Sales Growth

Stock News
·
May 13

Legend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss

Simply Wall St.
·
May 13

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Tvardi Therapeutics (TVRD) and Organigram Global (OGI)

TIPRANKS
·
May 13